Related Experiment Video
Updated: Nov 9, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease
Federica Rossi1, Einar Svarstad2, Hassan Elsaid3
1Department of Medicine and Surgery, University of Milano-Bicocca, Via G.B. Pergolesi, 33, 20900, Monza, Italy. f.rossi92@campus.unimib.it.
Insights
Hypertension is present in some Fabry disease patients, especially those with progressive organ damage. Ambulatory blood pressure monitoring is crucial for detecting masked hypertension and improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Genetics
Background:
- Published data on hypertension in Anderson-Fabry disease is limited.
- The impact of elevated blood pressure on organ damage in Fabry disease is not well understood.
Purpose of the Study:
- To assess blood pressure values in Fabry disease patients.
- To correlate blood pressure with clinical findings and organ involvement.
Main Methods:
- Prospective enrollment of adult Fabry patients (n=32).
- Collected genotype and clinical data.
- Utilized office, ambulatory, and home blood pressure monitoring.
- Assessed organ involvement (kidneys, heart, brain) and used the Fabry Stabilization Index.
Main Results:
- Hypertension diagnosed in 9.37% by office, 18.75% by ambulatory monitoring (3 masked cases).
- Hypertensive patients (all female) showed lower GFR and advanced cardiac hypertrophy.
- Progressive disease forms were more common in hypertensive patients (66.7%) versus normotensive (15.4%).
- No correlation found between hypertension and Fabry disease mutation type.
Conclusions:
- Hypertension occurs in a subset of stable Fabry patients.
- Progressive organ involvement, especially renal, increases risk for uncontrolled blood pressure.
- Ambulatory blood pressure monitoring is vital for detecting masked hypertension and guiding management.
- Proper hypertension diagnosis and treatment can improve Fabry disease outcomes.
Abstract:
INTRODUCTION: Published data on hypertension incidence and management in Anderson-Fabry disease are scant and the contribution of elevated blood pressure to organ damage is not well recognized.
Aim:
Therefore, we have assessed blood pressure values and their possible correlations with clinical findings in a well described cohort of Fabry patients.
Methods:
Between January 2015 and May 2019, all adult Fabry patients (n = 24 females, n = 8 males) referred to our institute were prospectively enrolled. During the first examination patient's genotype and clinical characteristics were recorded. Blood pressure data were obtained by standard observed office measurements followed, within 6 months, by ambulatory blood pressure monitoring and home self-recordings. Organ involvement, including kidneys, heart and brain, was monitored over time. Consequently, patients were defined as clinically stable or progressive through the Fabry Stabilization Index.
Results:
The standard office measurements have diagnosed hypertension in three (9.37%) patients, but the ambulatory monitoring showed elevated blood pressure in six (18.75%) patients, revealing three cases of masked hypertension. All the hypertensive patients were females and, compared with normotensive subjects, they presented a lower glomerular filtration rate (p < 0.05) and a more advanced cardiac hypertrophy (p < 0.05). Four (66.7%) of them were diagnosed with a progressive form of the disease through the Fabry Stabilization Index while the majority of the normotensive group (84.6%, n = 19) was stable over time. No correlation was found between the prevalence of hypertension and the type of mutations causing Fabry disease.
Conclusion:
Hypertension can be found in a restricted portion of clinically stable Fabry patients. In contrast, patients presenting with a progressive organ involvement, particularly renal impairment, have a major risk of developing uncontrolled blood pressure, and should be followed carefully. Moreover, the ambulatory blood pressure monitoring proved to be useful to reveal masked hypertension, which can contribute to the progressive worsening of the organ damage. Therefore, a proper diagnosis and therapy of hypertension may improve the outcome of Fabry patients.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Measurement of Blood Pressure
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):